Accelmed Partners is a lower middle-market private equity firm focused on acquiring and investing in mature, U.S.-based, commercial-stage HealthTech companies, including medical devices, diagnostics, digital health, and tech-enabled healthcare services.
86% of their portfolio is in Healthcare. Average disclosed round size is $39.1M (across 14 rounds with reported amounts).
Portfolio
12
Fund Size
$400M
Top Stage
Unknown
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 GT Medical Technologies | Series D | $53M | Jul 2025 |
 Corvia | Growth | $55M | Jun 2025 |
 Acclaro | Series B | $23M | Jun 2025 |
| GT Medical Technologies | Series D | $37M | Jan 2025 |
 Acclaro Medical | Series B | $23M | Jan 2025 |
| Acclaro | Series B | $23M | Jan 2025 |
 Memic | Series D | $96M | Apr 2021 |
 Click Therapeutics | Series B | $48.5M | Jan 2021 |
 NeuroPace | Unknown | $67M | Jan 2020 |
 EndoGastric Solutions, Inc. | Growth | $45M | May 2019 |
 CartiHeal | Unknown | $18.3M | Jan 2017 |
 TailorMed | Unknown | $40M | — |
 Strata Skin Sciences | Unknown | $17M | — |
| EEximo Medical | Series A | $1.6M | — |
Top Co-Investors
3E Bioventures Capital3 shared
Peregrine Ventures2 shared
VMG Partners2 shared
MedTech Venture Partners2 shared
Gilde Healthcare2 shared
Evidity Health Capital2 shared
Revelation Partners2 shared
OurCrowd1 shared
Accel1 shared
Illumina Ventures1 shared
General Catalyst1 shared
Third Rock Ventures1 shared
W Health Ventures1 shared
Advanced Technology Ventures1 shared
Samsung Next1 shared
BrightEdge1 shared
UnityPoint Health Ventures1 shared
Triventures1 shared
OSF HealthCare1 shared
Windham Capital Partners1 shared
Last updated: 20 October 2026